(Q37878064)

24 August 2017

1 reference

title

In-vitro assessment of platelet function (English)

1 reference

24 August 2017

Susanne M Picker

1

1 reference

24 August 2017

23 May 2011

1 reference

Transfusion and Apheresis Science

24 August 2017

1 reference

24 August 2017

44

1 reference

24 August 2017

3

1 reference

24 August 2017

305-319

1 reference

Platelet count, mean platelet volume and thrombocytopoietic indices in healthy women and men

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The mechanism of apoptosis in human platelets during storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Current methods of assessing platelet function: relevance to transfusion medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Inherited platelet-based bleeding disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelets in atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

7 January 2021

Platelet function assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet function analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Evaluation of platelet turnover by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Monitoring of platelet morphology during storage of platelet concentrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet size has diagnostic predictive value in patients with thrombocytopenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Correlation of in vivo and in vitro functions of fresh and stored human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Storage and quality assessment of platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Methods for evaluation of platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Metabolic patterns of platelets--impact on storage for transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The Platelet Response to Hypotonic Shock. Its Value as an Indicator of Platelet Viability After Storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The relation between response to hypotonic stress and the 51Cr recovery in vivo of preserved platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Annexin V Release and Transmembrane Mitochondrial Potential during Storage of Apheresis-Derived Platelets Treated for Pathogen Reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

A critical reappraisal of the bleeding time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Bleeding time, stroke and myocardial infarction: the Caerphilly prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Central laboratory and point of care assessment of perioperative hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Rebuttal to "Aspirin response variability assessed with the PFA-100 device" by Reny et al

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Response to aspirin and clopidogrel monitored with different platelet function methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet function abnormalities in qualified whole-blood donors: effects of medication and recent food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

High incidence of defective high-shear platelet function among platelet donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact-R).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Cone and platelet analyser (CPA): a new test for the prediction of bleeding among thrombocytopenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Use of the DiaMed Impact R to test platelet function in stored platelet concentrates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Using cone and plate(let) analyzer to predict bleeding in cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Mechanism of interaction of ticlopidine and its analogues with the energy-conserving mechanism in mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Effects of ticlopidine, a new platelet antiaggregating agent, and its analogues on mitochondrial metabolism. Oxidative phosphorylation, protein synthesis and DNA polymerase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

THE AGGREGATION OF BLOOD PLATELETS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

A revised model of platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Red blood cells: their dual role in thrombus formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet interaction with subendothelium in a perfusion system: Physical role of red blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet storage at 22°C; metabolic, morphologic, and functional studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Decreased platelet aggregation of platelet concentrate during storage recovers in the body after transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

A comparison of Plateletworks and platelet aggregometry for the assessment of aspirin-related platelet dysfunction in cardiac surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Rapid platelet-function assay: an automated and quantitative cartridge-based method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Assessment of platelet function assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Thienopyridines in cardiovascular disease: focus on clopidogrel resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

RETRACTED: Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

In vitro platelet function of platelet concentrates prepared using three different apheresis devices determined by impedance and optical aggregometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Current options in platelet function testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Thrombelastography/thromboelastometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Multi-centre investigation on reference ranges for ROTEM thromboelastometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Laboratory markers of platelet activation and their clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The Clearance Mechanism of Chilled Blood Platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Role of platelet surface glycoprotein Ibalpha and P-selectin in the clearance of transfused platelet concentrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

In vitro evaluation of stored platelets: is there hope for predicting posttransfusion platelet survival and function?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Flow cytometry in analysis of cell cycle and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Storage of platelet concentrates after high-dose ultraviolet B irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Markers of apoptosis in cardiovascular tissues: focus on Annexin V.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Apoptotic activity in stored human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Platelet apoptosis in stored platelet concentrates and other models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

Dose of prophylactic platelet transfusions and prevention of hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

The biochemistry of programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.03.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSCI.2011.03.006

1 reference

24 August 2017

1 reference

PubMed ID

21601530